Stifel Reiterates Buy Rating on Biogen (BIIB)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Nasdaq hits near three-month low as Amazon, Intel rattle AI trade
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil set for fourth monthly gain as Hormuz tanker attack highlights supply risks
| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 253.78 +4.13 (1.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $249.65 | 52 Week High | $333.65 | |||
| Open | $255.39 | 52 Week Low | $223.02 | |||
| Day High | $258.73 | P/E | 32.49 | |||
| Day Low | $252.23 | EPS | $7.81 | |||
| Volume | 501,058 | |||||
